Abstract
A new magnetic resonance imaging contrast agent containing organophosphonate functional groups was synthesized in high yield by a simple synthesis procedure. This molecule exhibits much higher longitudinal water proton relaxivity (37.0 mM_1 s_1) than commercial Omniscan (Gd-DTPA BMA, 5.7 mM- s-1) at 0.35 T. Notably, the relaxivity is larger than that of carboxylated Gd@C82 (16.0 mM -1 s-1) under the same conditions, indicating that the functional groups have an important role on the image contrast enhancement. In addition, the introduction of phosphonate substituents may provide bone-targeting MRI contrast agents.
| Original language | English |
|---|---|
| Pages (from-to) | 2106-2109 |
| Number of pages | 4 |
| Journal | Chemistry of Materials |
| Volume | 20 |
| Issue number | 6 |
| DOIs | |
| Publication status | Published - 25 Mar 2008 |
| Externally published | Yes |